India to Poland: Mitomycin Export Trade Route

The India to Poland Mitomycin corridor is one of India's established pharmaceutical export routes, with 53 shipments documented worth a combined $157.2K USD. The route is dominated by INTAS PHARMACEUTICALS LTD, which alone accounts for roughly 37% of all export value, reflecting the consolidated nature of India's mitomycin manufacturing sector.

Across 15 active suppliers, the average shipment value stands at $3.0K USD — a figure that reflects both bulk commercial orders from large pharmaceutical companies and smaller specialty shipments. Sea freight dominates at 76% of all shipments, consistent with mitomycin's non-urgent bulk-order profile.

Shipment activity peaks during April–June, with an average transit time of 15 days port-to-port. The route has recorded an annual growth rate of 18.6%, placing it at rank #15 among India's top mitomycin export destinations globally.

On the import side, key buyers of Indian mitomycin in Poland include ACCORD HEALTHCARE POLSKA SP Z O O, AS PER INVOICE POLAND, TO THE ORDER and 22 others. ACCORD HEALTHCARE POLSKA SP Z O O is the single largest importer with 1 shipments valued at $57.6K USD.

India's mitomycin exports to Poland are driven primarily by a handful of large-scale manufacturers. INTAS PHARMACEUTICALS LTD with 1 shipments leads the pack, a pattern common in generic pharmaceutical corridors where manufacturing scale creates significant cost advantages. The presence of 15 active exporters signals a competitive but concentrated market — buyers in Poland benefit from supplier diversity while the top tier handles the majority of volume.

The top 3 suppliers — INTAS PHARMACEUTICALS LTD, VAMA LIFECARE PRIVATE LIMITED, LEOWIN HEALTHCARE LLP — together account for 80% of total trade value on this route. The average shipment value of $3.0K USD reflects a mix of bulk commercial orders and smaller specialty shipments.

Beyond the primary product category, shipments on this route include closely related formulations such as harmless medicine for human consumption mitomycin for injection usp 20mg/vial (vitomycin 20mg/vial) batch num and mitomycin 40mg injection mitomycine injection ip 40mg, suggesting that buyers in Poland tend to consolidate orders across related product lines from the same Indian supplier.

On the buying side, ACCORD HEALTHCARE POLSKA SP Z O O is the largest importer with 1 shipments worth $57.6K USD — representing 37% of all mitomycin imports from India on this route. A total of 25 buyers are active on this corridor.